MKC9989

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

MKC9989 是羟基芳基醛 (HAA) 的抑制剂。 MKC9989 还抑制 IRE1α，IC50 为 0.23 至 44 μM。

MKC9989 is an inhibitor of Hydroxy aryl aldehydes (HAA). MKC9989 also inhibits IRE1α with an IC50 of 0.23 to 44 μM.(In Vitro):MKC9989, significantly stabilizes the RIDD target CD59 mRNA when co-administered with thapsigargin relative to thapsigargin treatment alone and modestly increases levels of CD59 mRNA in non-stressed cells, the latter likely reflects the inhibition of baseline RIDD activity. In contrast to effects on XBP1 splicing, MKC9989 moderately stabilizes CD59 levels when administered 2 hour post treatment with thapsigargin..

At 10 μM concentration, MKC9989 completely inhibits both basal and thapsigargin induced splicing of XBP1 mRNA. These effects are observed even in cells pre-treated with thapsigargin, indicating that MKC9989 can fully reverse the onset of XPB1 splicing after the UPR is initiated. In parallel analysis, MKC9989, significantly stabilizes the RIDD target CD59 mRNAwhen co-administered with thapsigargin relative to thapsigargin treatment alone and modestly increases levels of CD59 mRNA in non-stressed cells, the latter likely reflects the inhibition of baseline RIDD activity. In contrast to effects on XBP1 splicing, MKC9989 moderately stabilizes CD59 levels when administered 2 hour post treatment with thapsigargin. Finally, the potency of MKC9989 against the splicing of XBP1 mRNA (EC50=0.33 μM) is comparable to its potency against RNA cleavage in vitro.

——

——

Others

Other Targets

——

——

——

1338934-20-5

336.34

C17H20O7

>98% (HPLC)

In Vitro:?DMSO : ≥ 50 mg/mL (148.66 mM)

COCCOCCc1c(C)c2cc(OC)c(O)c(C=O)c2oc1=O

——

(-20℃)

With Ice Pack

≥ 2 years